[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Malignant Glioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Malignant Glioma. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Malignant Glioma - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Malignant Glioma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Malignant Glioma development. The report provides ...

January 2020 60 pages

Malignant Mesothelioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Malignant Mesothelioma. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Malignant Mesothelioma - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Malignant Mesothelioma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Malignant Mesothelioma development. The report provides ...

January 2020 60 pages

Medullary Thyroid Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Medullary Thyroid Cancer. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Medullary Thyroid Cancer - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Medullary Thyroid Cancer The report also ...

January 2020 60 pages

Metastatic Hepatocellular Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Metastatic Hepatocellular Carcinoma. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Metastatic Hepatocellular Carcinoma - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Metastatic Hepatocellular Carcinoma The report also ...

January 2020 60 pages

Metastatic Hormone Refractory Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Metastatic Hormone Refractory Prostate Cancer. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2020

 US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Metastatic Hormone Refractory Prostate Cancer The report also ...

January 2020 60 pages

Metastatic Liver Cancer - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Metastatic Liver Cancer The report also ...

January 2020 60 pages

Metastatic Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Metastatic Prostate Cancer. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Metastatic Prostate Cancer - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Metastatic Prostate Cancer The report also ...

January 2020 60 pages

Metastatic Renal Cell Carcinoma (mRCC) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Metastatic Renal Cell Carcinoma (mRCC). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Metastatic Renal Cell Carcinoma (mRCC) - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Metastatic Renal Cell Carcinoma (mRCC) The report also ...

January 2020 60 pages

Moderate Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Moderate Psoriasis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 120 pages

Moderate Psoriasis - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Moderate Psoriasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Moderate Psoriasis development. The report provides ...

January 2020 60 pages

Mucopolysaccharidosis III - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Mucopolysaccharidosis III - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Mucopolysaccharidosis III development. The report provides ...

January 2020 60 pages

Myasthenia Gravis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Myasthenia Gravis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Mycosis Fungoides - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Mycosis Fungoides. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Mycosis Fungoides - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Mycosis Fungoides - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Mycosis Fungoides development. The report provides ...

January 2020 60 pages

Myelofibrosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Myelofibrosis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Nasopharyngeal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Nasopharyngeal Cancer. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Neuroblastoma - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Neuroblastoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Neuroblastoma development. The report provides detailed ...

January 2020 60 pages

Neurofibromatoses - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Neurofibromatoses - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Neurofibromatoses development. The report provides detailed ...

January 2020 120 pages

Nicotine Addiction - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Nicotine Addiction - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Nicotine Addiction development. The report provides ...

January 2020 60 pages

Nocturia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Nocturia. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Non Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Non Alcoholic Fatty Liver Disease (NAFLD). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Insight, 2020

 US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Non Alcoholic Fatty Liver Disease (NAFLD) The report also ...

January 2020 60 pages

Non-Small Cell Lung Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Non-Small Cell Lung Cancer. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Nosocomial Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Nosocomial Infections. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 120 pages

Nosocomial Infections - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Nosocomial Infections - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Nosocomial Infections development. The report provides ...

January 2020 60 pages

Oligodendroglioma - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Oligodendroglioma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Oligodendroglioma development. The report provides detailed ...

January 2020 90 pages

Open-Angle Glaucoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Open-Angle Glaucoma. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 120 pages

Opioid-Induced Constipation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Opioid-Induced Constipation. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Opioid-Induced Constipation - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Opioid-Induced Constipation - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Opioid-Induced Constipation development. The report provides ...

January 2020 120 pages

Optic Neuritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Optic Neuritis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Optic Neuritis - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Optic Neuritis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Optic Neuritis development. The report provides ...

January 2020 60 pages

Oral Mucositis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Oral Mucositis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Oral Mucositis - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Oral Mucositis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Oral Mucositis development. The report provides ...

January 2020 60 pages

Otitis Media - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Otitis Media. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Otitis Media - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Otitis Media - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Otitis Media development. The report provides ...

January 2020 60 pages

Pancreatic Ductal Adenocarcinoma - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Pancreatic Ductal Adenocarcinoma The report also ...

January 2020 60 pages

Pancreatic Endocrine Tumor - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Pancreatic Endocrine Tumor The report also ...

January 2020 60 pages

Pancreatitis - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Pancreatitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pancreatitis development. The report provides detailed ...

January 2020 60 pages

Papillary Thyroid Cancer - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Papillary Thyroid Cancer The report also ...

January 2020 60 pages

Paroxysmal Nocturnal Hemoglobinuria - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Paroxysmal Nocturnal Hemoglobinuria. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Partial Seizure - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Partial Seizure. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Partial Seizure - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Partial Seizure - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Partial Seizure development. The report provides ...

January 2020 120 pages

Peanut Allergy - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Peanut Allergy. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1